Retatrutide is still investigational — not FDA-approved yet. The dosing and lean-mass questions people ask online mostly come from published phase 2 trials. Here's what those trials actually used and measured. WHAT IT IS Retatrutide is a "triple agonist." It acts on three gut-hormone signals: GLP-1, GIP, and glucagon. That is one step beyond dual agonists like tirzepatide. It is given as a once-weekly injection in the trials. WHAT PEOPLE USE IT FOR (IN RESEARCH) • Weight loss in adults with obesity or overweight • Blood sugar and metabolic outcomes in type 2 diabetes trials • Body-composition questions (fat vs lean mass), which show up a lot in community discussion WHY ONCE A WEEK, AND WHY IT STEPS UP In the main phase 2 obesity trial (NEJM, 2023), retatrutide was injected under the skin once a week for 48 weeks. Groups used target doses of 1 mg, 4 mg, 8 mg, or 12 mg. For the higher targets, people started lower and stepped up about every 4 weeks, for up to 12 weeks, mainly to limit stomach side effects. That step-up design is trial protocol, not a personal dosing plan. WHAT THE RESEARCH ACTUALLY SHOWS (WEIGHT) • At 48 weeks in that obesity trial, average weight loss reached about 24% at the highest dose group, versus about 2% on placebo. • Evidence level for weight change in phase 2: Strong for a mid-stage trial (large human trial, still not the final approval package). WHAT ABOUT LEAN MASS? Big weight loss always raises the "did I lose muscle too?" question. A 2025 body-composition substudy in people with type 2 diabetes used DXA scans. Fat mass fell more than lean mass. At the higher retatrutide doses, average fat loss was roughly 10–11 kg, while lean-mass loss was roughly 6–6.5 kg. So lean tissue did go down, but fat made up more of the total change. Evidence level for body composition: Early to Moderate (useful DXA substudy; not the same as every person's outcome). COMMON QUESTIONS Is there an approved weekly schedule? Not yet for retatrutide. Weekly dosing exists in trials. Approved schedules belong to finished, labeled products.

💪 ENCLOMIPHENE: WHAT IS IT? Enclomiphene shows up a lot when people want higher testosterone without shutting down their own production the way injectable TRT often does. Here's what it is in plain English. WHAT IT IS Enclomiphene is one half of clomiphene (Clomid). Clomiphene is a mix of two similar molecules: enclomiphene and zuclomiphene. Enclomiphene is the part that mainly raises LH and FSH, the brain signals that tell the testes to make testosterone and sperm. It is a SERM (selective estrogen receptor modulator). It is not FDA-approved as a finished product for men; most use discussed online is investigational or compounded. WHAT PEOPLE USE IT FOR Keeping or raising the body's own testosterone when the problem is low LH signaling • Trying to keep or improve fertility while raising testosterone • An alternative path for some men who are not ready for (or don't want) exogenous TRT • Sometimes discussed after testosterone or steroid use as part of restart talk (that use is off-label and not well standardized) WHAT THE RESEARCH ACTUALLY SHOWS • In men with secondary hypogonadism, clinical trials of oral enclomiphene raised testosterone and kept sperm production better than exogenous testosterone in the same studies. • It works by blocking estrogen feedback at the pituitary/hypothalamus, so LH and FSH go up and the testes stay active. • Evidence level: Moderate for raising testosterone and preserving sperm counts in the published trial programs. It is not an FDA-approved men's drug, so long-term outcome data and product quality (especially compounded versions) matter. COMMON QUESTIONS Is enclomiphene the same as Clomid? Not exactly. Clomid contains both enclomiphene and zuclomiphene. Enclomiphene is the isomer that drives most of the LH/FSH rise; zuclomiphene sticks around longer and may add more side-effect baggage for some people. Is it TRT? No. TRT replaces testosterone from outside. Enclomiphene tries to make your own system produce more. Different tools, different monitoring, different tradeoffs.

🌸 HORMONE THERAPY IN PERIMENOPAUSE: WHAT IT IS AND WHO IT'S FOR Hot flashes, broken sleep, mood swings, and periods that suddenly make no sense. Hormone therapy is the most effective treatment for many of these symptoms, and it's also one of the most misunderstood. WHAT IT IS Perimenopause is the transition before menopause. It often starts in your 40s and can last several years. Hormones swing up and down during this time. Menopause itself is one point in time: 12 months in a row with no period. Hormone therapy (often called HRT, or MHT for menopausal hormone therapy) replaces some of the estrogen your ovaries are making less of. • Estrogen treats the symptoms. It comes as a pill, patch, gel, or spray. • If you still have a uterus, you also need a progestogen (progesterone or a similar hormone). It protects the uterine lining. Estrogen alone can make that lining overgrow and raise the risk of uterine cancer. • Low-dose vaginal estrogen is a separate, local option for dryness, painful sex, and some urinary symptoms. WHY WOMEN ASK ABOUT IT • Hot flashes and night sweats • Poor sleep • Vaginal dryness and painful sex • Protecting bone • Mixed messages: "HRT causes cancer" vs "HRT fixes everything" WHAT THE RESEARCH SHOWS • Humans: The Menopause Society's 2022 position statement calls hormone therapy the most effective treatment for hot flashes and night sweats. It also prevents bone loss and fractures. For healthy women under 60, or within 10 years of menopause, with no reasons to avoid it, it says the benefits generally outweigh the risks for bothersome symptoms. • The big scare came from the Women's Health Initiative (WHI) trial, reported in 2002. Its participants averaged 63 years old, older than most women starting therapy. They took one older type of pill. Later analyses by age found lower risks in women who started closer to menopause. • Risks are real but depend on type, dose, route (pill vs skin), age, and timing. Pills raise blood clot risk. Large observational studies suggest estrogen through the skin carries less clot risk, but that hasn't been proven in head-to-head trials.

Thymalin shows up a lot in bioregulator conversations next to words like "immune" and "thymus." It is not the same thing as Thymosin Alpha-1 or the short synthetic peptides that came later. Here's the simple version. WHAT IT IS Thymalin is a peptide complex taken from calf thymus tissue (the thymus is a gland that helps train immune cells). A research group in Russia developed it decades ago as an immune-support medicine. Unlike a single lab-made sequence such as Epitalon, Thymalin is a mixture of thymus peptides. Researchers later linked some of its activity to short pieces inside that mixture, including KE, EW, and EDP. WHAT PEOPLE USE IT FOR • Immune support, especially in older adults • Recovery when immune markers look "run down" • Aging-related immune decline (sometimes called immunosenescence) WHAT THE RESEARCH ACTUALLY SHOWS • Cells: studies report effects on immune-cell differentiation and gene activity tied to those short peptides. • Animals: immune and aging models from the same research tradition. • Humans: there are real clinical papers, mostly from the originating research groups. Older long-term studies in elderly people reported fewer respiratory illnesses and lower mortality versus controls. A 2021 study in older patients with severe COVID-19 reported faster recovery of some immune markers and lower hospital mortality when Thymalin was added to standard care. Large, independent, multi-country replications are still limited. Evidence level: Early. More human reports than many bioregulators, but much of the work comes from the same research circle and needs broader confirmation. COMMON QUESTIONS Is Thymalin the same as Thymosin Alpha-1? No. Thymosin Alpha-1 is one defined 28-amino-acid peptide (sold as Zadaxin in some countries). Thymalin is a thymus tissue extract / peptide complex. Is it the same as Thymogen? No. Thymogen is usually the defined dipeptide EW. Thymalin is the broader extract that may contain EW among other pieces. Does it "boost" the immune system for healthy young people? That is not what the better-studied use cases focus on. Most published human work is in older adults or people with clear immune stress.

🧪 MY FAVORITE STACKS: MUSCLE BUILDING & PERFORMANCE When I talk about building muscle, I don't mean chasing one "magic" compound. I mean supporting growth, recovery, sleep, strength, and hormone signaling from a few different angles. Here's one stack I like for that goal — and why the pieces belong together. WHAT'S IN IT • CJC-1295 + Ipamorelin — growth-hormone pulse support • IGF-1 LR3 — growth and recovery signaling • FLGR-242 — myostatin / follistatin pathway • Kisspeptin — brain-to-testes hormone signaling • Testagen — testicular / endocrine bioregulator support WHY I USE IT / WHAT IT'S FOR The goal is to support muscle growth, recovery, sleep, strength, and anabolic signaling through multiple pathways: GH, IGF-1, myostatin/follistatin, and testosterone/reproductive hormone signaling. I don't stack these because "more is better." I stack them because they hit muscle-building biology from different directions. HOW THE PIECES WORK TOGETHER • CJC-1295 + Ipamorelin: CJC works through the GHRH pathway; Ipamorelin works through the ghrelin / GH secretagogue receptor. Together they support stronger natural GH pulses. Simple version: more GH signaling support for recovery, sleep, fat metabolism, and muscle-building environment. • IGF-1 LR3: a longer-acting IGF-1 form meant to activate the IGF-1 receptor pathway more strongly. Simple version: a direct growth and repair signal aimed at muscle tissue. • FLGR-242: built around the follistatin / myostatin pathway. Myostatin acts like a natural brake on muscle growth. Simple version: instead of only pressing the gas, this targets one of the brakes. • Kisspeptin: stimulates the KISS1 → GnRH → LH/FSH → testosterone pathway. Simple version: tells the brain to send stronger signals to the reproductive hormone system. • Testagen: the short peptide KEDG, used as a bioregulator focused on testicular and endocrine function. Simple version: support for the system that produces and regulates male hormones. Breakdown I keep in my head: